To include your compound in the COVID-19 Resource Center, submit it here.

ENMD-2076: Phase II data

A Phase II trial in 46 evaluable patients showed that once-daily ENMD-2076 produced

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE